ALNYLAM PHARMACEUTICALS, INC. Public Float
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Public Float of $42.63 billion as of 2025-06-30, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-12
- 2025-06-30: Entity Public Float $42.63B.
- 2024-06-30: Entity Public Float $30.99B.
- 2023-06-30: Entity Public Float $23.65B.
- 2022-06-30: Entity Public Float $17.60B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $42.63B 10-K · filed 2026-02-12 |
| 2024-06-30 | $30.99B 10-K · filed 2025-02-13 |
| 2023-06-30 | $23.65B 10-K · filed 2024-02-15 |
| 2022-06-30 | $17.60B 10-K · filed 2023-02-23 |
| 2021-06-30 | $20.00B 10-K · filed 2022-02-10 |
| 2020-06-30 | $16.99B 10-K · filed 2021-02-11 |
| 2019-06-28 | $8.00B 10-K · filed 2020-02-13 |
| 2018-06-29 | $9.82B 10-K · filed 2019-02-14 |
| 2017-06-30 | $7.24B 10-K · filed 2018-02-15 |
| 2016-06-30 | $4.70B 10-K · filed 2017-02-15 |
| 2015-06-30 | $10.04B 10-K · filed 2016-02-12 |
| 2014-06-30 | $4.77B 10-K · filed 2015-02-13 |
| 2013-06-28 | $1.92B 10-K · filed 2014-02-20 |
| 2012-06-30 | $532.32M 10-K · filed 2013-02-19 |
| 2011-06-30 | $290.09M 10-K · filed 2012-02-13 |
| 2010-06-30 | $446.58M 10-Q · filed 2011-11-03 |
| 2009-06-30 | $916.01M 10-Q · filed 2010-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |